Why is Galapagos GLPG stock going up today Q4 2025 EPS Beats Forecasts CHSCN CHS Pref B quarterly earnings core metrics remain unreleased as the firm finalizes its official filing NRXP NRX Pharmaceuticals shares climb 352 percent as investors shrug off worse than expected Q4 2025 EPS miss